What is the current Cell Viability Assays market size?

The Cell Viability Assays market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Cell Viability Assays market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Cell Viability Assays market?

Key drivers include rising research investments and growing applications in pharmaceutical and biotechnology industries.

What are the major challenges facing the Cell Viability Assays market?

Challenges include high costs of assays and limited awareness of advanced technologies in emerging economies.

Which regions are leading the Cell Viability Assays market?

North America and Europe are currently leading the market due to strong research infrastructure.

Who are the top companies in the Cell Viability Assays market?

Top companies include Thermo Fisher, Merck, and Promega, offering a range of assay products and services.

What future opportunities exist in the Cell Viability Assays market?

Future opportunities include emerging applications in personalized medicine and increasing adoption in Asia-Pacific regions.

How is technology impacting the Cell Viability Assays market?

Advances in technologies like high-content screening and 3D cell culture are enhancing assay sensitivity and efficiency.

What is the current regulatory landscape for the Cell Viability Assays market?

The regulatory landscape is governed by guidelines from FDA and EU regulatory bodies, ensuring assay quality and safety.

What is the future outlook for the Cell Viability Assays market?

The future outlook is positive, with growing demand for efficient and accurate cell viability assays driving market growth.

Cell Viability Assays Growth, Trends & Forecast Outlook 2033

Cell Viability Assays by Application (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital and Diagnostic Laboratories, Others), by Types (Human Cells, Microbial Cells, Animal Cells), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Cell Viability Assays Market Size | CAGR 12.8 Forecast 2033

Cell Viability Assays Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Cell Viability Assays Market Overview

The Cell Viability Assays market refers to the industry involved in developing and marketing assays used to measure the viability of cells, which is crucial in various biomedical research and pharmaceutical applications. As the Cell Viability Assays market size is expected to grow significantly, driven by increasing demand for effective and accurate cell viability assessment, the growth outlook and market forecast are of paramount importance for industry stakeholders. The industry expansion is anticipated to be shaped by factors such as advancements in technology, rising investments in life sciences research, and growing applications in drug discovery and development. The current Cell Viability Assays market size is approximately $1.4 billion, according to recent market research.

Loading chart…

The Cell Viability Assays market is expected to grow at a CAGR of around 8-10% during the forecast period, driven by macro drivers such as increasing investments in life sciences research, growing applications in drug discovery and development, and advancements in technology. Key forces shaping the industry include technology shifts towards more accurate and efficient assays, regulations supporting the use of cell viability assays in various applications, and competitive intensity among market players. The largest region in the Cell Viability Assays market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing investments in life sciences research and growing demand for cell viability assays in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	3.23 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Merck; Bio-Rad; GE; Danaher; BD; PerkinElmer; Promega; Biotium; Abcam; Creative Bioarray; Biotek Instruments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cell Viability Assays market is poised for significant growth, driven by increasing demand for efficient and accurate cell viability assessment methods. The Cell Viability Assays market size is expected to expand substantially, with a promising growth forecast, driven by advancements in technology and rising adoption across various industries.

Growth Drivers2 items

Advancements in cell viability assay technologies, such as high-throughput screening and 3D cell culture, are driving the adoption of these assays in research and development applications, thereby contributing to the growth of the Cell Viability Assays market.

Increasing investments in life sciences research and development, particularly in the pharmaceutical and biotechnology sectors, are fueling the demand for cell viability assays, further augmenting the Cell Viability Assays market size.

Restraints2 items

High costs associated with cell viability assay kits and equipment, as well as the requirement for specialized expertise, are limiting the adoption of these assays in small and medium-sized research institutions, thereby restraining the growth of the Cell Viability Assays market.

Stringent regulatory frameworks governing the use of cell viability assays in certain applications, such as in vivo testing, are hindering the growth forecast of the Cell Viability Assays market.

Opportunities2 items

The increasing focus on personalized medicine and targeted therapies is creating opportunities for the development and adoption of innovative cell viability assays, which can provide more accurate and efficient assessment of cell health, thereby driving the growth of the Cell Viability Assays market size.

The growing demand for cell viability assays in emerging economies, driven by increasing investments in life sciences research and development, is expected to provide new growth avenues for the Cell Viability Assays market, with a promising growth forecast.

Challenges2 items

The lack of standardization in cell viability assay protocols and data analysis is a significant challenge facing the Cell Viability Assays market, as it can lead to variability in results and hinder the comparison of data across different studies.

The need for continuous innovation and development of new cell viability assay technologies, in order to keep pace with the evolving needs of researchers and clinicians, is a major challenge for manufacturers in the Cell Viability Assays market, affecting the overall growth forecast.

Market Segmentation

Loading chart…

The Application segment in the Cell Viability Assays market refers to the various uses of these assays in research and development, diagnostics, and other fields. This segment is crucial in understanding the Cell Viability Assays segmentation, as it highlights the diverse applications of these assays, contributing significantly to the overall market size. The application segment can be further divided into subtypes, including drug discovery, basic research, and diagnostics, each with its own set of requirements and growth prospects.

The Types segment in the Cell Viability Assays market encompasses various assay formats, including luminescent, fluorescent, and colorimetric assays. Each type has its own strengths and limitations, and understanding the market taxonomy of these types is essential for industry players to navigate the competitive landscape. The types segment can be further broken down into subtypes, such as ATP assays, MTT assays, and XTT assays, which cater to different research needs and contribute to the overall growth of the Cell Viability Assays market.

Cell Viability Assays Segmentation Breakdown9 items

Application

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Hospital and Diagnostic Laboratories

Others

Types

Human Cells

Microbial Cells

Animal Cells

Regional Insights

Loading chart…

The Cell Viability Assays market growth is expected to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the global market, driven by key factors such as high adoption rates of cell viability assays in research institutions, favorable policies supporting biomedical research, and significant investments in life sciences infrastructure. Europe is the second-largest region, with a share of around 30%, driven by a mature ecosystem of pharmaceutical and biotechnology companies, a large demographics of aging population, and a well-established infrastructure for research and development.

The fastest-growing region is Asia Pacific, with a projected regional forecast of 10% annual growth rate, driven by increasing adoption of cell viability assays in emerging economies, government policies supporting the growth of biotechnology industry, and rising investments in research and development infrastructure. Latin America and Middle East & Africa are also expected to witness significant growth, driven by growing demographics and increasing infrastructure development in these regions.

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, significant investments

Europe: mature ecosystem, large demographics, well-established infrastructure

Asia Pacific: increasing adoption, government policies, rising investments

Latin America: growing demographics, increasing infrastructure development

Middle East & Africa: growing demographics, increasing infrastructure development

Competitive Landscape

The Cell Viability Assays market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. The Cell Viability Assays competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and customization to cater to specific customer needs.

Companies in the Cell Viability Assays market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on innovation, customer satisfaction, and operational efficiency.

Thermo Fisher Scientific: regional expansion

Merck: innovation pipeline

Bio-Rad: premium pricing

GE: OEM tie-ups

Danaher: vertical integration

BD: local manufacturing

Key Cell Viability Assays Companies12 items

Thermo Fisher Scientific

Merck

Bio-Rad

Danaher

PerkinElmer

Promega

Biotium

Abcam

Creative Bioarray

Biotek Instruments

Market Ecosystem

The Cell Viability Assays ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value creation and capture occur through the development, manufacturing, and distribution of cell viability assays, which are critical for various applications in research, diagnostics, and therapeutics. The ecosystem's boundaries are defined by the interactions among these stakeholders, influencing how value flows and is captured.

Raw material suppliers — providing reagents and chemicals

Technology providers — developing assay kits and instruments

OEMs / manufacturers — producing assay kits and equipment

Distributors / channel partners — supplying products to end users

Service providers / after-sales — offering technical support and maintenance

End users / buyers — utilizing cell viability assays in research and diagnostics

Regulators/standards bodies — establishing guidelines and standards

In the Cell Viability Assays ecosystem, control points are primarily held by technology providers and regulators, as they influence adoption through innovation and standardization. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the development and distribution of cell viability assays. Furthermore, switching costs and partnerships between stakeholders can affect the ecosystem's dynamics, particularly in regions with diverse regulatory requirements, highlighting the need for a thorough value chain analysis to understand these complex interactions.

Recent Industry Insights

The Cell Viability Assays industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major pharmaceutical companies and research institutions, have driven innovation in the field. Additionally, there have been notable mergers and acquisitions, including the acquisition of a leading life sciences company by a prominent biotechnology firm. Furthermore, several product and technology launches have taken place, enhancing the capabilities of cell viability assays. Regulatory changes, such as updated guidelines for cell-based research, have also impacted the industry. These developments have contributed to a shift in consumer and enterprise trends, with an increased focus on personalized medicine and targeted therapies. Funding rounds and expansions have also been announced, supporting the growth of the Cell Viability Assays market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Cell Viability Assays market outlook. The market exhibits high attractiveness due to increasing demand for effective and efficient cell viability assessment methods in various industries. The competitive intensity is moderate, with key players investing in research and development to enhance their product offerings. The long-term outlook is positive, driven by advancements in technology and growing applications in fields such as cancer research and regenerative medicine.

The innovation landscape is dynamic, with emerging trends such as high-content screening and 3D cell culture gaining traction. The demand-supply balance is stable, with manufacturers catering to the rising demand for cell viability assays. However, key risk factors such as stringent regulations and technological disruptions may impact market growth. Overall, the Cell Viability Assays market outlook is favourable, presenting opportunities for investors and industry stakeholders.

11 items

1. Executive Summary

2. Cell Viability Assays Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cell Viability Assays Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cell Viability Assays Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical and Biotechnology Companies

6.1.2. Academic and Research Institutes

6.1.3. Hospital and Diagnostic Laboratories

6.1.4. Others

6.2. Global Cell Viability Assays Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Human Cells

6.2.2. Microbial Cells

6.2.3. Animal Cells

6.3. Global Cell Viability Assays Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cell Viability Assays Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cell Viability Assays Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cell Viability Assays Market Competition by Key Manufacturers

8.1. Global Cell Viability Assays Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cell Viability Assays: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merck

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Rad

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GE

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BD

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. PerkinElmer

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Promega

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Biotium

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Abcam

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Creative Bioarray

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Biotek Instruments

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cell Viability Assays Market

Figure 4: Global Cell Viability Assays Market: Drivers

Figure 5: Global Cell Viability Assays Market: Challenges

Figure 6: Global Cell Viability Assays Market: Trends

Figure 7: Global Cell Viability Assays Market: Opportunity

Figure 8: Global Cell Viability Assays Market: Restraint

Figure 9: Global Cell Viability Assays Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cell Viability Assays Market Value (USD Million) By Region

Figure 15: Global Cell Viability Assays Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cell Viability Assays Market Value (USD Million) By Region

Figure 23: Global Cell Viability Assays Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Cell Viability Assays Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cell Viability Assays Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cell Viability Assays Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cell Viability Assays Market Value (USD Million) By Region

Table 10: Global Cell Viability Assays Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cell Viability Assays Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cell Viability Assays Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cell Viability Assays Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Merck Basic Information And Sales Area

Table 33: Merck. Products Portfolio

Table 34: Bio-Rad Basic Information And Sales Area

Table 35: Bio-Rad. Products Portfolio

Table 36: GE Basic Information And Sales Area

Table 37: GE. Products Portfolio

Table 38: Danaher Basic Information And Sales Area

Table 39: Danaher. Products Portfolio

Table 40: BD Basic Information And Sales Area

Table 41: BD. Products Portfolio

Table 42: PerkinElmer Basic Information And Sales Area

Table 43: PerkinElmer. Products Portfolio

Table 44: Promega Basic Information And Sales Area

Table 45: Promega. Products Portfolio

Table 46: Biotium Basic Information And Sales Area

Table 47: Biotium. Products Portfolio

Table 48: Abcam Basic Information And Sales Area

Table 49: Abcam. Products Portfolio

Table 50: Creative Bioarray Basic Information And Sales Area

Table 51: Creative Bioarray. Products Portfolio

Table 52: Biotek Instruments Basic Information And Sales Area

Table 53: Biotek Instruments. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Cell Viability Assays Market Value (USD Million) By Region

Table 59: Global Cell Viability Assays Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Cell Viability Assays Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	3.23 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Merck; Bio-Rad; GE; Danaher; BD; PerkinElmer; Promega; Biotium; Abcam; Creative Bioarray; Biotek Instruments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options